A Case of Fulminant Type 1 Diabetes Mellitus with Human Leukocyte Antigen DR4-DQ4

被引:0
作者
So, Ye-Ri [1 ]
Koo, Ja-Won [1 ]
Cho, Young-Hak [1 ]
Hwang, You-Cheol [1 ]
Ahn, Kyu-Jeung [1 ]
Chung, Ho-Yeon [1 ]
Jeong, In-Kyung [1 ]
机构
[1] Kyung Hee Univ, Kyung Hee Univ Hosp Gangdong, Sch Med, Dept Endocrinol & Metab, 892 Dongnam Ro, Seoul 134727, South Korea
关键词
HLA antigens; Type 1 diabetes mellitus;
D O I
10.3803/EnM.2012.27.4.314
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The clinical characteristics of fulminant type 1 diabetes are abrupt onset of disease, very short (<1 week) duration of diabetic symptoms, ketoacidosis at diagnosis, negativity for islet-related autoantibodies, virtually no C-peptide secretion (fasting plasma C-peptide < 0.3 ng/mL), a near normal hemoglobin A1c (HbA1c) level and an elevated serum pancreatic enzyme level. The pathogenesis has not yet been clarified, however the involvement of both genetic background and viral infections has been suggested. We reported a case of fulminant type 1 diabetes. A 37-year-old woman was admitted with stuporous consciousness to our hospital. Four days prior to the admission, she was hospitalized with the diagnosis of acute pancreatitis in another hospital, and at that time her glucose level was 79 mg/dL. Three days after the hospitalization, her state of consciousness became stuporous and she was transferred to our hospital. The laboratory results were as follows: pH 6.94, glucose 1,602 mg/dL, and HbA1c 5.5%. She was negative for islet-related autoantibodies and viral antibodies. HLA haplotypes were DRB1*04:05/*04: 06, DQB1*03:02/*04:01 which might be a considerable risk allele for fulminant type 1 diabetes. She was diagnosed with fulminant type 1 diabetes, and has been treated with multiple component insulin regimens.
引用
收藏
页码:314 / 317
页数:4
相关论文
共 21 条
[1]  
Akatsuka Hajime, 2009, Diabetes Res Clin Pract, V84, pe50, DOI 10.1016/j.diabres.2009.03.009
[2]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[3]  
2-S
[4]   ISLET-CELL ANTIBODIES IN DIABETES-MELLITUS WITH AUTOIMMUNE POLY-ENDOCRINE DEFICIENCIES [J].
BOTTAZZO, GF ;
FLORINCH.A ;
DONIACH, D .
LANCET, 1974, 2 (7892) :1279-1283
[5]   Case of fulminant type 1 diabetes associated with significant elevation of mumps titers [J].
Goto, Atsushi ;
Takahashi, Yoshihiko ;
Kishimoto, Miyako ;
Nakajima, Yoshifumi ;
Nakanishi, Koji ;
Kajio, Hiroshi ;
Noda, Mitsuhiko .
ENDOCRINE JOURNAL, 2008, 55 (03) :561-564
[6]   Different contribution of class IIHLA in fulminant and typical autoimmune type 1 diabetes mellitus [J].
Imagawa, A ;
Hanafusa, T ;
Uchigata, Y ;
Kanatsuka, A ;
Kawasaki, E ;
Kobayashi, T ;
Shimada, A ;
Shimizu, I ;
Maruyama, T ;
Makino, H .
DIABETOLOGIA, 2005, 48 (02) :294-300
[7]   Fulminant type 1 diabetes - A nationwide survey in Japan [J].
Imagawa, A ;
Hanafusa, T ;
Uchigata, Y ;
Kanatsuka, A ;
Kawasaki, E ;
Kobayashi, T ;
Shimada, A ;
Shimizu, I ;
Toyoda, T ;
Maruyama, T ;
Makino, H .
DIABETES CARE, 2003, 26 (08) :2345-2352
[8]   A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. [J].
Imagawa, A ;
Hanafusa, T ;
Miyagawa, J ;
Matsuzawa, Y .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (05) :301-307
[9]   A proposal of three distinct subtypes of type 1 diabetes mellitus based on clinical and pathological evidence [J].
Imagawa, A ;
Hanafusa, T ;
Miyagawa, J ;
Matsuzawa, Y .
ANNALS OF MEDICINE, 2000, 32 (08) :539-543
[10]  
Imagawa Akihisa, 2006, Rev Diabet Stud, V3, P169, DOI 10.1900/RDS.2006.3.169